Kopka K - Search Results

1

Combination of [¹⁸F]FDG and [¹⁸F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer.

Kim J, Lee S, Kim D, Kim HJ, Oh KT, Kim SJ, Choi YD, Giesel FL, Kopka K, Hoepping A, Lee M, Yun M. Kim J, et al. Among authors: kopka k. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1763-1772. doi: 10.1007/s00259-023-06585-7. Epub 2024 Jan 11. Eur J Nucl Med Mol Imaging. 2024. PMID: 38200396

2

Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [¹⁸F]LUZ5-d₈.

Ueberham L, Gündel D, Kellert M, Deuther-Conrad W, Ludwig FA, Lönnecke P, Kazimir A, Kopka K, Brust P, Moldovan RP, Hey-Hawkins E. Ueberham L, et al. Among authors: kopka k. J Med Chem. 2023 Apr 13;66(7):5242-5260. doi: 10.1021/acs.jmedchem.3c00195. Epub 2023 Mar 21. J Med Chem. 2023. PMID: 36944112 Free PMC article.

3

Synthesis, Structure-Activity Relationships, Radiofluorination, and Biological Evaluation of [¹⁸F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET.

Teodoro R, Gündel D, Deuther-Conrad W, Kazimir A, Toussaint M, Wenzel B, Bormans G, Hey-Hawkins E, Kopka K, Brust P, Moldovan RP. Teodoro R, et al. Among authors: kopka k. J Med Chem. 2023 Oct 26;66(20):13991-14010. doi: 10.1021/acs.jmedchem.3c01035. Epub 2023 Oct 10. J Med Chem. 2023. PMID: 37816245 Free PMC article.

4

Preclinical evaluation of an ¹⁸F-labeled N^ε-acryloyllysine piperazide for covalent targeting of transglutaminase 2.

Wodtke R, Laube M, Hauser S, Meister S, Ludwig FA, Fischer S, Kopka K, Pietzsch J, Löser R. Wodtke R, et al. Among authors: kopka k. EJNMMI Radiopharm Chem. 2024 Jan 2;9(1):1. doi: 10.1186/s41181-023-00231-1. EJNMMI Radiopharm Chem. 2024. PMID: 38165538 Free PMC article.

5

Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al¹⁸F/⁶⁸Ga/¹¹¹In.

Sihver W, Walther M, Ullrich M, Nitt-Weber AK, Böhme J, Reissig F, Saager M, Zarschler K, Neuber C, Steinbach J, Kopka K, Pietzsch HJ, Wodtke R, Pietzsch J. Sihver W, et al. Among authors: kopka k. Bioconjug Chem. 2024 Sep 18;35(9):1402-1416. doi: 10.1021/acs.bioconjchem.4c00313. Epub 2024 Aug 26. Bioconjug Chem. 2024. PMID: 39185789 Free PMC article.

6

¹⁸Fluorine Prostate-specific Membrane Antigen 1007 Positron Emission Tomography for High-risk Prostate Cancer.

Froehner M, Görner M, Merkle L, Kopka K, Zöphel K. Froehner M, et al. Among authors: kopka k. Urology. 2024 May;187:96-97. doi: 10.1016/j.urology.2024.02.037. Epub 2024 Feb 28. Urology. 2024. PMID: 38423393 No abstract available.

7

Scalability study on [¹³³La]LaCl₃ production with a focus on potential clinical applications.

Brühlmann SA, Walther M, Blei MK, Mamat C, Kopka K, Freudenberg R, Kreller M. Brühlmann SA, et al. Among authors: kopka k. EJNMMI Radiopharm Chem. 2024 Aug 15;9(1):60. doi: 10.1186/s41181-024-00292-w. EJNMMI Radiopharm Chem. 2024. PMID: 39147960 Free PMC article.

8

The heterobivalent (SSTR2/albumin) radioligand [⁶⁷Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics.

Ullrich M, Wodtke R, Brandt F, Freudenberg R, Kotzerke J, Richter S, Kopka K, Pietzsch J. Ullrich M, et al. Among authors: kopka k. Theranostics. 2024 Aug 26;14(14):5371-5387. doi: 10.7150/thno.100091. eCollection 2024. Theranostics. 2024. PMID: 39310112 Free PMC article.

9

Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends.

Zippel C, Ermert J, Patt M, Gildehaus FJ, Ross TL, Reischl G, Kuwert T, Solbach C, Neumaier B, Kiss O, Mitterhauser M, Wadsak W, Schibli R, Kopka K. Zippel C, et al. Among authors: kopka k. Front Nucl Med. 2022 Apr 14;2:850414. doi: 10.3389/fnume.2022.850414. eCollection 2022. Front Nucl Med. 2022. PMID: 39354976 Free PMC article.

10

Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging.

Löser R, Kuchar M, Wodtke R, Neuber C, Belter B, Kopka K, Santhanam L, Pietzsch J. Löser R, et al. Among authors: kopka k. ChemMedChem. 2023 Sep 15;18(18):e202300331. doi: 10.1002/cmdc.202300331. Epub 2023 Sep 4. ChemMedChem. 2023. PMID: 37565736 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters